Abbreviations AA: Arachidonic acid ATF6: Activating transcription factor-6 CHOP: C/EBP homologous protein CIH: Chronic intermittent hypoxia CVD: Cardiovascular disease CYPs: Cytochromes P450 DG: Diacylglycerol DGATs: Diacylglycerol acyltransferases DHA: Docosahexaenoic acid DNL: De novo lipogenesis DPA: Docosapentaenoic acid EPA: Eicosapentaenoic acid ER: Endoplasmic reticulum FAO: Fatty acid oxidation FAT/CD36: Fatty acid translocase FATPs: Fatty acid transport proteins FFAs: Free fatty acids GPL: Glycerophospholipid GRP78: Glucose-regulated protein 78/immunoglobulin-heavy-chain-binding protein GSDMD: Gasdermin D HIFs: Hypoxia-inducible factors IR: Insulin resistance IRE1: Inositol-requiring kinase 1 JNKs: c-Jun N-terminal kinases LAL: Lysosomal acid lipase LDL: Low-density lipoprotein LPL: Lipoprotein lipase LPS: Lipopolysaccharides LyPC: Lysophosphatidylcholine MAFLD: Metabolic associated fatty liver disease MLKL: Mixed lineage kinase domain-like NAFL: Non-alcoholic fatty liver NAFLD: Non-alcoholic fatty liver disease NASH: Non-alcoholic steatohepatitis NLRP3: NACHT, LRR and PYD domains-containing protein 3 OSAS: Obstructive sleep apnea syndrome PC: Phosphatidylcholine PE: Phosphatidylethanolamine PERK: Double-stranded RNA-dependent protein kinase-like ER kinase PI: Phosphatidylinositol PUMA: p53 upregulated modulator of apoptosis RIP: Receptor-interacting protein ROS: Reactive oxygen species SREBPs: Sterol regulatory element binding proteins SERCA2: Sarco/endoplasmic reticulum Ca 2+ -ATPase 2 TGs: Triglycerides TRAIL: TNF-related apoptosis-inducing ligand UPR: Unfolded protein response VLDL: Very-low-density-lipoprotein WAT: White adipose tissue References Eslam M, et al
An observational study indicated higher carotenoid intake was associated with greater sperm motility, and lycopene intake specifically was correlated with better sperm morphology
We know that long-duration proton pump inhibitor (PPI) use is often associated with lower magnesium levels and deficiency. Meacham says
Examples include: Wound repair models that require fibroblast migration, extracellular matrix deposition, and remodeling Tendon/ligament repair models focused on cell survival, growth and restoration of tissue organization[1] Research in fibrosis and remodeling where thymosin beta-4 related pathways are of interest[2] Studies associated with angiogenesis (e.g., when vascular support is a limiting factor in tissue regeneration) [5] Since synergy is an outcome claim that must be demonstrated experimentally, it is hypothesized here: if BPC-157 and TB-500 affect different critical points of repair (e.g., gene expression versus cytoskeleton mobilization), combined administration in preclinical designs could produce additive or multiplicative improvements in migration rate, wound closure, tissue organization, or histological markers of remodeling, depending on the model and evaluation criteria
